Correlation Between Kura Oncology and Akero Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kura Oncology and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kura Oncology and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kura Oncology and Akero Therapeutics, you can compare the effects of market volatilities on Kura Oncology and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kura Oncology with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kura Oncology and Akero Therapeutics.

Diversification Opportunities for Kura Oncology and Akero Therapeutics

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Kura and Akero is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Kura Oncology and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Kura Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kura Oncology are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Kura Oncology i.e., Kura Oncology and Akero Therapeutics go up and down completely randomly.

Pair Corralation between Kura Oncology and Akero Therapeutics

Given the investment horizon of 90 days Kura Oncology is expected to under-perform the Akero Therapeutics. In addition to that, Kura Oncology is 2.2 times more volatile than Akero Therapeutics. It trades about -0.22 of its total potential returns per unit of risk. Akero Therapeutics is currently generating about 0.14 per unit of volatility. If you would invest  2,971  in Akero Therapeutics on August 27, 2024 and sell it today you would earn a total of  302.00  from holding Akero Therapeutics or generate 10.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Kura Oncology  vs.  Akero Therapeutics

 Performance 
       Timeline  
Kura Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kura Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Akero Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Akero Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Akero Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Kura Oncology and Akero Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kura Oncology and Akero Therapeutics

The main advantage of trading using opposite Kura Oncology and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kura Oncology position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.
The idea behind Kura Oncology and Akero Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites